Objective: We examined what was known about individuals in Canada who were assessed as being at moderate risk for future fracture. Methods: A scoping review was conducted. Eligible articles were Canadian studies published from 2010 onwards reporting on primary data that included patients at moderate risk for future fracture. We limited the search to Canada as fracture risk categorization is unique to each country. Studies were identified by searching relevant databases. Two reviewers independently reviewed titles and abstracts to determine each study’s eligibility. General information about each study, demographic information about the moderate risk groups (including tool used to determine moderate risk (Fracture Risk Assessment Tool (FRAX), Canadian Association of Radiologists and Osteoporosis Canada (CAROC)), and outcomes (number of patients: recommended treatment, prescribed treatment, initiating treatment, persisting with treatment after six months, who refractured, who died) were documented. Results: We identified 1193 papers which were further screened for eligibility. Of the 1193 identified, 7 were eligible for the review but only 4 articles contained demographic or outcome data on moderate risk patients. In one study, 1.8% of moderate risk patients died over a mean 5.3 years of observation and in three studies, the risk of fracture was 5.9% over a median of 3 years of follow-up, 8.3% over a mean of 5.4 years, and 14.7% over 10 years of follow-up. Conclusion: There is a wide knowledge gap in the literature concerning individuals who are assessed as moderate risk for future fracture in Canada.
References
[1]
Compston, J., Bowring, C., Cooper, A., Cooper, C., Davies, C., Francis, R., Kanis, J.A., Marsh, D., McCloskey, E.V., Reid, D.M. and Selby, P., National Osteoporosis Guideline Group (2013) Diagnosis and Management of Osteoporosis in Post-menopausal Women and Older Men in the UK: National Osteoporosis Guideline Group (NOGG) Update 2013. Maturitas, 75, 392-396. http://dx.doi.org/10.1016/j.maturitas.2013.05.013
[2]
Compston, J., Cooper, A., Cooper, C., Francis, R., Kanis, J.A., Marsh, D., McCloskey, E.V., Reid, D.M., Selby, P. and Wilkins, M., National Osteoporosis Guideline Group (NOGG) (2009) Guidelines for the Diagnosis and Management of Osteoporosis in Postmenopausal Women and Men from the Age of 50 Years in the UK. Maturitas, 62, 105-108. http://dx.doi.org/10.1016/j.maturitas.2008.11.022
[3]
Papaioannou, A., Morin, S., Cheung, A.M., Atkinson, S., Brown, J.P., Feldman, S., Hanley, D.A., Hodsman, A., Jamal, S.A., Kaiser, S.M., Kvern, B., Siminoski, K. and Leslie, W.D., Scientific Advisory Council of Osteoporosis Canada (2010) 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. Canadian Medical Association Journal, 182, 1864-1873. http://dx.doi.org/10.1503/cmaj.100771
[4]
Leslie, W.D., Lix, L.M., Johansson, H., Oden, A., McCloskey, E. and Kanis, J.A. (2010) Independent Clinical Validation of a Canadian FRAX Tool: Fracture Prediction and Model Calibration. Journal of Bone & Mineral Research, 25, 2350-2358. http://dx.doi.org/10.1002/jbmr.123
[5]
Leslie, W.D., Berger, C., Langsetmo, L., Lix, L.M., Adachi, J.D., Hanley, D., Ioannidis, G., Josse, R., Kovacs, C., Towheed, T.E., Kaiser, S.M., Olszynski, W.P., Prior, J., Jamal, S., Kreiger, N. and Goltzman, D., Canadian Multicentre Osteoporosis Study Research Group (2011) Construction and Validation of a Simplified Fracture Risk Assessment Tool for Canadian Women and Men: Results from the CaMos and Manitoba Cohorts. Osteoporosis International, 22, 1873-1883. http://dx.doi.org/10.1007/s00198-010-1445-5
[6]
World Health Organization (1994) Assessment of Fracture Risk and Application to Screening for Postmenopausal Osteoporosis.
[7]
Arksey, H. and O’Malley, L. (2005) Scoping Studies: Towards a Methodological Framework. International Journal of Social Research Methodology, 8, 19-32. http://dx.doi.org/10.1080/1364557032000119616
[8]
Levac, D., Colquhoun, H. and O’Brien, K.K. (2010) Scoping Studies: Advancing the Methodology. Implementation Science, 5, 69. http://dx.doi.org/10.1186/1748-5908-5-69
[9]
Daudt, H.M.L., van Mossel, C. and Scott, S.J. (2013) Enhancing the Scoping Study Methodology: A Large, Interprofessional Team’s Experience with Arksey and O’Malley’s Framework. BMC Medical Research Methodology, 13, 48. http://dx.doi.org/10.1186/1471-2288-13-48
[10]
Rumrill, P.D., Fitzgerald, S.M. and Merchant, W.R. (2010) Using Scoping Literature Reviews as a Means of Understanding and Interpreting Existing Literature. Work, 35, 399-404.
[11]
The Cochrane Collaboration (2014) Cochrane Organizational Policy Manual. Oxford.
[12]
Sale, J.E.M., Beaton, D., Posen, J., Elliot-Gibson, V. and Bogoch, E. (2011) Systematic Review on Interventions to Improve Osteoporosis Investigation and Treatment in Fragility Fracture Patients. Osteoporosis International, 22, 2067-2082. http://dx.doi.org/10.1007/s00198-011-1544-y
[13]
Ganda, K.P.M., Chen, J.S., Speerin, R., Beasel, J., Center, J.R., Eisman, J.A., March, L. and Seibel, M.J. (2013) Models of Care for the Secondary Prevention of Osteoporotic Fractures: A Systematic Review and Meta-Analysis. Osteoporosis International, 24, 393-406. http://dx.doi.org/10.1007/s00198-012-2090-y
[14]
Little, E.A. and Eccles, M.P. (2010) A Systematic Review of the Effectiveness of Interventions to Improve Post-Fracture Investigation and Management of Patients at Risk of Osteoporosis. Implementation Science, 5, 80. http://dx.doi.org/10.1186/1748-5908-5-80
[15]
Bell, K., Strand, H. and Inder, W.J. (2013) Effect of a Dedicated Osteoporosis Health Professional on Screening and Treatment in Outpatients Presenting with Acute Low Trauma Non-Hip Fracture: A Systematic Review. Archives of Osteoporosis, 9, 167.
[16]
Sale, J.E.M., Beaton, D., Posen, J., Elliot-Gibson, V. and Bogoch, E. (2014) Key Outcomes Are Usually Not Reported in Published Fracture Secondary Prevention Programs: Results of a Systematic Review. Archives of Orthopaedic and Trauma Surgery, 134, 283-289. http://dx.doi.org/10.1007/s00402-011-1442-y
[17]
Sale, J.E.M., Beaton, D., Posen, J. and Bogoch, E. (2013) Medication Initiation Rates Are Not Directly Comparable across Secondary Fracture Prevention Programs: Reporting Standards Based on a Systematic Review. Journal of Clinical Epidemiology, 66, 379-385.e4. http://dx.doi.org/10.1016/j.jclinepi.2012.10.013
[18]
Brennan, S.L., Leslie, W.D., Lix, L.M., Johansson, H., Oden, A., McCloskey, E. and Kanis, J.A. (2014) FRAX Provides Robust Fracture Prediction Regardless of Socioeconomic Status. Osteoporosis International, 25, 61-69. http://dx.doi.org/10.1007/s00198-013-2525-0
[19]
Leslie, W.D., Lix, L.M. and Wu, X., On behalf of the Manitoba Bone Density Program (2013) Competing Mortality and Fracture Risk Assessment. Osteoporosis International, 24, 681-688. http://dx.doi.org/10.1007/s00198-012-2051-5
[20]
Leslie, W.D., Kovacs, C.S., Olszynski, W.P., Towheed, T., Kaiser, S.M., Prior, J.C., Josse, R.G., Jamal, S.A., Kreiger, N. and Goltzman, D., the CaMos Research Group (2011) Spine-Hip T-Score Difference Predicts Major Osteoporotic Fracture Risk Independent of FRAX: A Population-Based Report from CAMOS. Journal of Clinical Densitometry, 14, 286-293. http://dx.doi.org/10.1016/j.jocd.2011.04.011
[21]
Leslie, W.D., Morin, S., Lix, L.M., Johansson, H., Oden, A., McCloskey, E. and Kanis, J.A., for the Manitoba Bone Density Program (2012) Fracture Risk Assessment without Bone Density Measurement in Routine Clinical Practice. Osteoporosis International, 23, 75-85. http://dx.doi.org/10.1007/s00198-011-1747-2
[22]
Giangregorio, L.M., Leslie, W.D., Lix, L.M., Johansson, H., Oden, A., McCloskey, E. and Kanis, J.A. (2012) FRAX Underestimates Fracture Risk in Patients with Diabetes. Journal of Bone and Mineral Research, 27, 301-308. http://dx.doi.org/10.1002/jbmr.556
[23]
Roux, S., Cabana, F., Carrier, N., Beaulieu, M., April, P.M., Beaulieu, M.C. and Boire, G. (2014) The World Health Organization Fracture Risk Assessment Tool (FRAX) Underestimates Incident and Recurrent Fractures in Consecutive Patients with Fragility Fractures. Journal of Clinical Endocrinology & Metabolism, 99, 2400-2408. http://dx.doi.org/10.1210/jc.2013-4507
[24]
Allin, S., Munce, S.S.A.M., Hawker, G., Murphy, K. and Jaglal, S.B. (2013) Quality of Fracture Risk Assessment in Post-Fracture Care in Ontario, Canada. Osteoporosis International, 24, 899-905. http://dx.doi.org/10.1007/s00198-012-2111-x
[25]
Papaioannou, A., Morin, S., Cheung, A.M., Atkinson, S., Brown, J., Feldman, S., Hanley, D.A., Hodsman, A., Jamal, S.A., Josse, R.G., Kaiser, S.M., Kvern, B., Siminoski, K. and Leslie, W.D., for the Scientific Advisory Council of Osteoporosis Canada (2010) Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada: Background and Technical Report, 1-89.
[26]
Bogoch, E.R., Cheung, A.M., Elliot-Gibson, V.I.M. and Gross, D.K. (2010) Preventing the Second Hip Fracture: Addressing Osteoporosis in Hip Fracture Patients. In: Waddell, J.P., Ed., Fractures of the Proximal Femur, Elsevier, Maryland Heights.
[27]
Wall, M., Lohfeld, L., Giangregorio, L., Ioannidis, G., Kennedy, C.C., Moser, A., Papaioannou, A. and Morin, S.N. (2013) Fracture Risk Assessment in Long-Term Care: A Survey of Long-Term Care Physicians. BMC Geriatrics, 13, 109-115. http://dx.doi.org/10.1186/1471-2318-13-109
